Cite

HARVARD Citation

    Sorger, H. et al. (2022). Blocking STAT3/5 through direct or upstream kinase targeting in leukemic cutaneous T‐cell lymphoma. EMBO molecular medicine. 14 (12), p. n/a. [Online]. 
  
Back to record